Trump calls Chinese startup DeepSeek's cheaper AI methods "a positive," as U.S. tech stocks plunge amid market sell-off.

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

DeepSeek’s latest models, created by a small company with limited resources, are already beating many of the leading AI ...

OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, ...

Chinese startup DeepSeek didn't just match Big Tech's AI capabilities—it completely rewrote the rules of what's possible with ...

The company said it had spent just $5.6 million powering its base AI model, compared with the hundreds of millions, if not ...

US stocks dropped sharply Monday morning after a surprise advancement from a Chinese artificial intelligence company, DeepSeek, threatened the aura of invincibility surrounding America’s technology ...

DeepSeek was reportedly developed in just two months at a cost of under $6 million — a stark contrast to the billions ...

It's Musk vs Altman - again. But look away from the griping and sniping and the more interesting developments relate to ...

More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...

OpenAI CEO Sam Altman is under fire for suggesting that artificial intelligence will upend societal norms after President ...